The products and information provided by Rebirth Labs are not intended to diagnose, treat, cure, or prevent any disease
Since this medication is administered by a healthcare professional in a medical setting, an overdose is unlikely to occur
Addition of 5 g/mL BPC-157 stimulated a morphological change in HUVECs without significantly increasing the tube network formation, whereby increasing the dose to 10 g/mL caused greater tube formation compared to control
Studied primarily for tissue repair, angiogenic effects, and growth factor signaling
Cagrilintide shows greater potency and a longer half-life (approximately 7 days) than earlier amylin analogs like Pramlintide, which is why its generating attention in the metabolic optimization space
This reagent is a systemic form of RUO lyophilized reconstitution vial intended for laboratory testing and NOT a cosmetic product or drug